Deutsche Bank’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $693K | Sell |
30,018
-69,673
| -70% | -$1.61M | ﹤0.01% | 2283 |
|
|
2025
Q1 | $2.69M | Buy |
99,691
+6,662
| +7% | +$180K | ﹤0.01% | 1550 |
|
|
2024
Q4 | $4.98M | Buy |
93,029
+73,912
| +387% | +$3.96M | ﹤0.01% | 1321 |
|
|
2024
Q3 | $868K | Buy |
19,117
+6,693
| +54% | +$304K | ﹤0.01% | 2144 |
|
|
2024
Q2 | $520K | Buy |
12,424
+5,699
| +85% | +$239K | ﹤0.01% | 2285 |
|
|
2024
Q1 | $253K | Sell |
6,725
-248
| -4% | -$9.34K | ﹤0.01% | 2669 |
|
|
2023
Q4 | $74.8K | Hold |
6,973
| – | – | ﹤0.01% | 3293 |
|
|
2023
Q3 | $70.3K | Hold |
6,973
| – | – | ﹤0.01% | 3289 |
|
|
2023
Q2 | $82.8K | Sell |
6,973
-3,485
| -33% | -$41.4K | ﹤0.01% | 3341 |
|
|
2023
Q1 | $127K | Buy |
10,458
+2,245
| +27% | +$27.2K | ﹤0.01% | 3211 |
|
|
2022
Q4 | $108K | Buy |
8,213
+114
| +1% | +$1.5K | ﹤0.01% | 3285 |
|
|
2022
Q3 | $110K | Sell |
8,099
-1,143
| -12% | -$15.5K | ﹤0.01% | 3247 |
|
|
2022
Q2 | $113K | Sell |
9,242
-1,356
| -13% | -$16.6K | ﹤0.01% | 3446 |
|
|
2022
Q1 | $152K | Buy |
10,598
+1,980
| +23% | +$28.4K | ﹤0.01% | 3381 |
|
|
2021
Q4 | $170K | Buy |
8,618
+433
| +5% | +$8.54K | ﹤0.01% | 3420 |
|
|
2021
Q3 | $178K | Buy |
+8,185
| New | +$178K | ﹤0.01% | 3591 |
|